Tamar Securities
BMY icon

Tamar Securities’s Bristol-Myers Squibb BMY Stock Holding History

Tamar Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$423K Sell
6,781
-2,301
-25% -$145K 0.04% 62
2026
Q2 		$523K Buy
9,082
+2,000
+28% +$115K 0.05% 62
2026
Q1 		$430K Sell
7,082
-907
-11% -$52.9K 0.05% 59
2025
Q4 		$431K Sell
7,989
-5,427
-40% -$261K 0.05% 58
2025
Q3 		$605K Sell
13,416
-329,066
-96% -$15.4M 0.07% 53
2025
Q2 		$15.9M Buy
342,482
+17,027
+5% +$836K 1.92% 24
2025
Q1 		$19.8M Sell
325,455
-92,655
-22% -$5.4M 2.69% 15
2024
Q4 		$23.6M Buy
418,110
+3,950
+1% +$221K 3.26% 10
2024
Q3 		$21.4M Buy
414,160
+33,073
+9% +$1.55M 3.01% 12
2024
Q2 		$15.8M Buy
381,087
+93,685
+33% +$4.19M 2.57% 14
2024
Q1 		$15.6M Buy
287,402
+52,993
+23% +$2.7M 2.63% 12
2023
Q4 		$12M Buy
234,409
+27,758
+13% +$1.46M 2.36% 21
2023
Q3 		$12M Buy
206,651
+32,368
+19% +$1.98M 2.89% 9
2023
Q2 		$11.1M Buy
174,283
+24,068
+16% +$1.61M 2.74% 12
2023
Q1 		$10.4M Buy
150,215
+13,665
+10% +$964K 2.99% 12
2022
Q4 		$9.8M Buy
136,550
+250
+0.2% +$18.8K 3.12% 12
2022
Q3 		$9.7M Buy
136,300
+27,259
+25% +$1.98M 3.1% 9
2022
Q2 		$8.4M Sell
109,041
-25,926
-19% -$1.97M 2.76% 15
2022
Q1 		$9.9M Buy
134,967
+3,430
+3% +$230K 2.75% 14
2021
Q4 		$8.2M Sell
131,537
-3,676
-3% -$216K 2.42% 15
2021
Q3 		$8M Buy
135,213
+9,698
+8% +$639K 2.89% 12
2021
Q2 		$8.39M Buy
125,515
+12,985
+12% +$847K 3.23% 11
2021
Q1 		$7.1M Buy
112,530
+19,357
+21% +$1.2M 2.75% 12
2020
Q4 		$5.78M Buy
93,173
+8,106
+10% +$498K 3.29% 10
2020
Q3 		$5.13M Buy
85,067
+16,303
+24% +$981K 3.19% 10
2020
Q2 		$4.04M Buy
+68,764
New +$4.11M 3.22% 11

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Tamar Securities's BMY Position: Q3 2026 in Review

Tamar Securities reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q3 2026, selling an estimated $145K and leaving 6,781 shares worth $423K. The position accounts for 0.04% of the portfolio, ranked #62.

Tamar Securities first reported a position in BMY in Q2 2020 and has held it in 26 quarters since. The position peaked at $23.6M in Q4 2024. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Tamar Securities held 6,781 shares of Bristol-Myers Squibb worth $423K as of Q3 2026.
  • Tamar Securities sold 2,301 Bristol-Myers Squibb shares in Q3 2026, an estimated $145K.
  • Bristol-Myers Squibb made up 0.04% of Tamar Securities's portfolio in Q3 2026, its #62 holding.
  • Tamar Securities first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 26 quarters since.
  • Tamar Securities's Bristol-Myers Squibb position peaked at $23.6M in Q4 2024.
  • 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Tamar Securities's 13F filing for Q3 2026, filed 3 Nov 2026.